Brain Organoids, Lessons from Fetal Neocortex Formation, and Rational Design for Quality Control.
Publication Year:
2026
PubMed ID:
42244543
Funding Grants:
Public Summary:
Human brain organoids are three-dimensional, laboratory-grown models that reproduce important features of early brain development and provide valuable opportunities to study neurological disorders and test potential treatments. However, differences in organoid development and quality can affect experimental results and limit the reliability of research findings. This study presents a systematic approach to improving brain organoid quality control by using knowledge of normal fetal brain development to guide laboratory practices.
The researchers examined the major stages of human neocortex formation and compared these developmental processes with those observed in cerebral organoid models. They developed a practical framework for identifying and removing improperly developing organoids during laboratory culture, helping researchers maintain more consistent and representative models. The study also presents preliminary work on an imaging and mesofluidic platform designed to monitor organoid development and support automated quality assessment.
By combining developmental biology with real-time imaging and standardized quality-control procedures, this approach aims to improve the consistency, reproducibility, and physiological relevance of brain organoid research. The framework may strengthen the use of human brain organoids for studying neurological diseases, evaluating potential therapies, and developing more standardized, high-throughput models for biomedical research.
Scientific Abstract:
Recent widespread adoption of cerebral organoid protocols has led to many new studies assessing the human-specific features of neural diseases. However, not all organoid studies employ proper quality control, which limits the physiological relevance of their findings. Here, we discuss the stages of in vivo neocortex formation and how those stages are recapitulated in organoid protocols. We then present the first guide for real-time operator removal of maldeveloped organoids in shaking culture. Finally, we show preliminary work on an organoid imaging and mesofluidic control platform for automated quality control of organoid development. Taken together, this approach for assessing the morphological features of organoids will improve the rigor and reproducibility of organoid studies, increase effect sizes of physiologically relevant disease etiology, and pave the way for cortical organoid GMP in high-throughput. CLINICAL RELEVANCE: This establishes high-throughput, visual brain organoid quality control for disease studies and preclinical testing.